ElectroCore. has been granted a patent for a vagal nerve stimulation device designed to treat medical conditions linked to low dopamine and endogenous opioids. The device uses electrodes to deliver electrical impulses transcutaneously, modulating the vagus nerve to stimulate dopamine production in the brain. GlobalData’s report on ElectroCore gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on ElectroCore, Cardiac stimulation implants was a key innovation area identified from patents. ElectroCore's grant share as of July 2024 was 63%. Grant share is based on the ratio of number of grants to total number of patents.
Vagal nerve stimulation device for treating medical conditions
The granted patent US12070593B2 describes a device designed for treating medical conditions by utilizing electrical impulses to modulate the vagus nerve in patients. The device features one or more electrodes that make contact with the outer skin surface, specifically targeting areas near the vagus nerve, such as the neck. A power source is integrated into the device, generating electrical impulses that consist of bursts of 2 to 20 pulses, with frequencies ranging from 5 Hz to 100 Hz. These impulses are intended to stimulate dopamine-producing neurons in the brain and can also promote the release of endogenous opioids or cannabinoids, as well as inhibitory neurotransmitters like GABA and glutamate.
Additionally, the device may include a housing that contains the power source and electrodes, with the possibility of incorporating a signal generator. The electrical impulses can be structured to alternate between positive and negative voltages, with specific pulse durations between 20 to 1000 microseconds. The method outlined in the patent involves positioning the electrodes on the patient's neck, generating the electrical impulses, and transmitting them transcutaneously to achieve the desired therapeutic effects. This innovative approach aims to provide a non-invasive treatment option for various medical conditions by leveraging the physiological effects of vagus nerve stimulation.
To know more about GlobalData’s detailed insights on ElectroCore, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
